Search Results 541-550 of 18340 for prednisone

  1. A Study of the Implementation, Safety, and Outcomes of OB Nest Model of Care for Expectant Mothers - Mayo Clinic

    Prednisone > 10mg per day; Antipsychotic (e.g. lithium, Haldol, Zyprexa); Chemotherapy. Recurrent pregnancy loss (>2 losses); Current maternal malignancy; Prior ...

  2. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    Prednisone or equivalent > 20 mg/day;; Or has not been on the current course for ≥ 14 days prior to Baseline and on a stable dose for ≥ 7 days prior ...

  3. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    Steroid dose should be 20 mg or less of prednisone/prednisolone daily, or equivalent of a different steroid. At least 2 weeks beyond high dose systemic ...

  4. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    Subjects with active autoimmune disease or any condition requiring systemic treatment with either corticosteroids (> 10 mg daily of prednisone equivalents) or ...

  5. Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis - Mayo Clinic

    Off prednisone or its equivalent for minimum 2 months prior to study entry. Access to a computer or smartphone/device. Exclusion Criteria: Uncontrolled ...

  6. What Are the Most Effective Treatments for Grover's Disease Itching? - Mayo Clinic News Network

    Answer: Grover's disease — also known as transient acantholytic dermatosis — is a condition where itchy red spots appear without warning, usually on a person's ...

  7. A Study Using Avelumab in Non-Small Cell Lung Cancer that has Progressed - Mayo Clinic

    ... prednisone per day; Administration of steroids through a route known to result in a minimal systemic exposure are acceptable; Previous or ongoing ...

  8. A Study to Evaluate AVB-S6-500 with Paclitaxel vs Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer - Mayo Clinic

    prednisone or equivalent or have demonstrated signs or symptoms of neurologic instability for 28 days or less prior to randomization. - Primary platinum ...

  9. Drugs and Supplements that Start with D - Mayo Clinic

    Prednisone (oral route). Delzicol. Also known as. Mesalamine (oral route). Demadex. Also known as. Torsemide (oral route). Demadex. Also known as. Torsemide ...

  10. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    disease (GVHD). - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) ...